BRAINCOOL AB (5YL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BRAINCOOL AB (5YL) has a cash flow conversion efficiency ratio of -0.095x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-15.85 Million ≈ $-18.53 Million USD) by net assets (€167.46 Million ≈ $195.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 5YL market cap for the company's overall valuation and market capitalisation.
BRAINCOOL AB - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how BRAINCOOL AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
BRAINCOOL AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BRAINCOOL AB ranked by their cash flow conversion efficiency. See BRAINCOOL AB cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Clarkson
LSE:CKN
|
-0.046x |
|
Australian Vintage Ltd
AU:AVG
|
0.195x |
|
Ever Shine Textile Industry
JK:ESTI
|
0.027x |
|
Kumpulan H & L High-Tech Bhd
KLSE:7033
|
0.035x |
|
Orpheus Uranium Ltd
AU:ORP
|
-0.119x |
|
Ecolomondo Corp
V:ECM
|
3.144x |
|
Woojin I&S Co Ltd
KO:010400
|
-0.025x |
|
Lancashire Holdings Ltd
LSE:LRE
|
0.018x |
Annual Cash Flow Conversion Efficiency for BRAINCOOL AB (2021–2025)
The table below shows the annual cash flow conversion efficiency of BRAINCOOL AB from 2021 to 2025. View 5YL share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €175.80 Million ≈ $205.53 Million |
€-52.68 Million ≈ $-61.58 Million |
-0.300x | +30.19% |
| 2024-12-31 | €145.93 Million ≈ $170.61 Million |
€-62.64 Million ≈ $-73.23 Million |
-0.429x | +21.58% |
| 2023-12-31 | €111.74 Million ≈ $130.63 Million |
€-61.16 Million ≈ $-71.50 Million |
-0.547x | -37.50% |
| 2022-12-31 | €116.23 Million ≈ $135.89 Million |
€-46.27 Million ≈ $-54.09 Million |
-0.398x | +25.74% |
| 2021-12-31 | €45.23 Million ≈ $52.88 Million |
€-24.25 Million ≈ $-28.35 Million |
-0.536x | -- |
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powe… Read more